During the past decade, Johanniter-Krankenhaus Bonn conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johanniter-Krankenhaus Bonn" #1 sponsor was "AGO Research GmbH" with 1 trials, followed by "Aktion Bronchialkarzinom e.V." with 1 trials sponsored, "Central European Society for Anticancer Drug Research" with 1 trials sponsored, "Dominik Paul Modest" with 1 trials sponsored and "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johanniter-Krankenhaus Bonn" #1 collaborator was "German Breast Group" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Johanniter-Krankenhaus Bonn" are "Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Colorectal Cancer" (2 trials), "Multiple Myeloma" (2 trials) and "Colorectal Carcinoma" (1 trials). Many other conditions were trialed in "Johanniter-Krankenhaus Bonn" in a lesser frequency.

Most popular intervention types in "Johanniter-Krankenhaus Bonn" are "Drug" (15 trials), "Biological" (3 trials), "Device" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Cisplatin" (2 trials), "Dexamethasone" (2 trials), "Erlotinib" (2 trials) and "Isatuximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Johanniter-Krankenhaus Bonn" are 10 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Johanniter-Krankenhaus Bonn". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Johanniter-Krankenhaus Bonn, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Johanniter-Krankenhaus Bonn, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".